{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:07:46Z","timestamp":1792058866318,"version":"4.4.0"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although the BCL6 transcriptional repressor is frequently expressed in human follicular lymphomas (FL), its biological role in this disease remains unknown. Herein, we comprehensively identify the set of gene promoters directly targeted by BCL6 in primary human FLs. We noted that BCL6 binds and represses NOTCH2 and NOTCH pathway genes. Moreover, BCL6 and NOTCH2 pathway gene expression is inversely correlated in FL. Notably, BCL6 upregulation is associated with repression of NOTCH2 and its target genes in primary human and murine germinal center (GC) cells. Repression of NOTCH2 is an essential function of BCL6 in FL and GC B cells because inducible expression of Notch2 abrogated GC formation in mice and killed FL cells. Indeed, BCL6-targeting compounds or gene silencing leads to the induction of NOTCH2 activity and compromises survival of FL cells, whereas NOTCH2 depletion or pathway antagonists rescue FL cells from such effects. Moreover, BCL6 inhibitors induced NOTCH2 expression and suppressed growth of human FL xenografts in vivo and primary human FL specimens ex vivo. These studies suggest that established FLs are thus dependent on BCL6 through its suppression of NOTCH2.<\/jats:p>\n                  <jats:p>Significance: We show that human FLs are dependent on BCL6, and primary human FLs can be killed using specific BCL6 inhibitors. Integrative genomics and functional studies of BCL6 in primary FL cells point toward a novel mechanism whereby BCL6 repression of NOTCH2 drives the survival and growth of FL cells as well as GC B cells, which are the FL cell of origin. Cancer Discov; 7(5); 506\u201321. \u00a92017 AACR.<\/jats:p>\n                  <jats:p>This article is highlighted in the In This Issue feature, p. 443<\/jats:p>","DOI":"10.1158\/2159-8290.cd-16-1189","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T20:40:26Z","timestamp":1487882426000},"page":"506-521","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells"],"prefix":"10.1158","volume":"7","author":[{"given":"Ester","family":"Valls","sequence":"first","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Lobry","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, New York."},{"name":"3Institut Gustave Roussy, INSERM U1170, Villejuif and Universit\u00e9 Paris Sud, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Geng","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."},{"name":"4Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York."},{"name":"5Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Cardenas","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Rivas","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Cerchietti","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philmo","family":"Oh","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Ning","family":"Yang","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Oswald","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille W.","family":"Graham","sequence":"additional","affiliation":[{"name":"6Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Hatzi","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."},{"name":"7Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Agirre","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."},{"name":"8Division of Hematology\/Oncology, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Perkey","sequence":"additional","affiliation":[{"name":"9Life Sciences Institute, Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan."},{"name":"10Graduate Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoning","family":"Li","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[{"name":"11Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Bhatt","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Zweidler-McKay","sequence":"additional","affiliation":[{"name":"6Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Maillard","sequence":"additional","affiliation":[{"name":"9Life Sciences Institute, Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Elemento","sequence":"additional","affiliation":[{"name":"4Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ci","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."},{"name":"12Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iannis","family":"Aifantis","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2017,4,30]]},"reference":[{"key":"2022060701032325200_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.hoc.2008.07.013","article-title":"Follicular lymphoma: clinical features and treatment","volume":"22","author":"Tan","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"2022060701032325200_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/ehm.09.49","article-title":"Biology and treatment of follicular lymphoma","volume":"2","author":"Piccaluga","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"2022060701032325200_bib3","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","article-title":"VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia","volume":"103","author":"Egle","year":"2004","journal-title":"Blood"},{"key":"2022060701032325200_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0046-8177(99)90141-7","article-title":"Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities","volume":"30","author":"Skinnider","year":"1999","journal-title":"Hum Pathol"},{"key":"2022060701032325200_bib5","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"key":"2022060701032325200_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2014.03.001","article-title":"Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis","volume":"20","author":"Hatzi","year":"2014","journal-title":"Trends Mol Med"},{"key":"2022060701032325200_bib7","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1182\/blood-2008-07-168773","article-title":"A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo","volume":"113","author":"Cerchietti","year":"2009","journal-title":"Blood"},{"key":"2022060701032325200_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1134","article-title":"Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells","volume":"10","author":"Polo","year":"2004","journal-title":"Nat Med"},{"key":"2022060701032325200_bib9","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0611399104","article-title":"Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas","volume":"104","author":"Polo","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060701032325200_bib10","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1182\/blood-2008-12-193037","article-title":"The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL","volume":"113","author":"Ci","year":"2009","journal-title":"Blood"},{"key":"2022060701032325200_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molcel.2007.09.027","article-title":"A universal framework for regulatory element discovery across all genomes and data types","volume":"28","author":"Elemento","year":"2007","journal-title":"Mol Cell"},{"key":"2022060701032325200_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"key":"2022060701032325200_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"2022060701032325200_bib14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","article-title":"Identification of genes periodically expressed in the human cell cycle and their expression in tumors","volume":"13","author":"Whitfield","year":"2002","journal-title":"Mol Biol Cell"},{"key":"2022060701032325200_bib15","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060701032325200_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","article-title":"Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"key":"2022060701032325200_bib17","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"2022060701032325200_bib18","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/MCB.01091-06","article-title":"Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc","volume":"26","author":"Sharma","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2022060701032325200_bib19","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev"},{"key":"2022060701032325200_bib20","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060701032325200_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","article-title":"Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development","volume":"18","author":"Saito","year":"2003","journal-title":"Immunity"},{"key":"2022060701032325200_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1532","article-title":"Reverse engineering of regulatory networks in human B cells","volume":"37","author":"Basso","year":"2005","journal-title":"Nat Genet"},{"key":"2022060701032325200_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J Exp Med"},{"key":"2022060701032325200_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.imlet.2007.04.009","article-title":"Bcl6 is required for the IL-4-mediated rescue of the B cells from apoptosis induced by IL-21","volume":"110","author":"Tsuruoka","year":"2007","journal-title":"Immunol Lett"},{"key":"2022060701032325200_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.stem.2013.05.015","article-title":"In vivo mapping of notch pathway activity in normal and stress hematopoiesis","volume":"13","author":"Oh","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2022060701032325200_bib26","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1073\/pnas.0602353103","article-title":"Tracking germinal center B cells expressing germ-line immunoglobulin gamma1 transcripts by conditional gene targeting","volume":"103","author":"Casola","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060701032325200_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.celrep.2013.06.016","article-title":"A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters","volume":"4","author":"Hatzi","year":"2013","journal-title":"Cell Rep"},{"key":"2022060701032325200_bib28","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1172\/JCI42869","article-title":"BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy","volume":"120","author":"Cerchietti","year":"2010","journal-title":"J Clin Invest"},{"key":"2022060701032325200_bib29","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-07-5817","article-title":"Sequential transcription factor targeting for diffuse large B-cell lymphomas","volume":"68","author":"Cerchietti","year":"2008","journal-title":"Cancer Res"},{"key":"2022060701032325200_bib30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"key":"2022060701032325200_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"key":"2022060701032325200_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4049\/jimmunol.0803183","article-title":"Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis","volume":"183","author":"Yoon","year":"2009","journal-title":"J Immunol"},{"key":"2022060701032325200_bib33","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1172\/JCI65477","article-title":"Blockade of individual Notch ligands and receptors controls graft-versus-host disease","volume":"123","author":"Tran","year":"2013","journal-title":"J Clin Invest"},{"key":"2022060701032325200_bib34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"2022060701032325200_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1087344","article-title":"Transcriptional repression of atherogenic inflammation: modulation by PPARdelta","volume":"302","author":"Lee","year":"2003","journal-title":"Science"},{"key":"2022060701032325200_bib36","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.4049\/jimmunol.169.4.1922","article-title":"Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene","volume":"169","author":"Vasanwala","year":"2002","journal-title":"J Immunol"},{"key":"2022060701032325200_bib37","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2005-01-0355","article-title":"Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies","volume":"106","author":"Zweidler-McKay","year":"2005","journal-title":"Blood"},{"key":"2022060701032325200_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.devcel.2009.12.023","article-title":"BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning","volume":"18","author":"Sakano","year":"2010","journal-title":"Dev Cell"},{"key":"2022060701032325200_bib39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/nn.3264","article-title":"BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets","volume":"15","author":"Tiberi","year":"2012","journal-title":"Nat Neurosci"},{"key":"2022060701032325200_bib40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2022060701032325200_bib41","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1182\/blood-2006-09-046698","article-title":"Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation","volume":"109","author":"Thomas","year":"2007","journal-title":"Blood"},{"key":"2022060701032325200_bib42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","article-title":"Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma","volume":"100","author":"Lee","year":"2009","journal-title":"Cancer Sci"},{"key":"2022060701032325200_bib43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.4428","article-title":"Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours","volume":"234","author":"Karube","year":"2014","journal-title":"J Pathol"},{"key":"2022060701032325200_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3324\/haematol.2014.116855","article-title":"The NOTCH pathway is recurrently mutated in diffuse large B cell lymphoma associated with hepatitis C virus infection","volume":"100","author":"Arcaini","year":"2014","journal-title":"Haematologica"},{"key":"2022060701032325200_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09999","article-title":"A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia","volume":"473","author":"Klinakis","year":"2011","journal-title":"Nature"},{"key":"2022060701032325200_bib46","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood-2007-01-069575","article-title":"BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms","volume":"110","author":"Parekh","year":"2007","journal-title":"Blood"},{"key":"2022060701032325200_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ni.2543","article-title":"Lineage-specific functions of BCL6 in immunity and inflammation are mediated through distinct biochemical mechanisms","volume":"14","author":"Huang","year":"2013","journal-title":"Nat Immunol"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/7\/5\/506\/1846679\/506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/7\/5\/506\/1846679\/506.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T21:03:50Z","timestamp":1654549430000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/7\/5\/506\/6325\/BCL6-Antagonizes-NOTCH2-to-Maintain-Survival-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,30]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,4,30]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-16-1189","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.22532023.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532044","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532047.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532023","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532035","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532047","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532041","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532032","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532038.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532050","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532044.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532041.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532029.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532035.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532026.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532032.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532026","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532038","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532029","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22532050.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.6546610","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6546610.v1","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,30]]}}}